{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:00:53Z","timestamp":1791356453816,"version":"4.3.1"},"reference-count":65,"publisher":"The Company of Biologists","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12,1]]},"abstract":"<jats:p>Heparan sulfate proteoglycans are essential for biological processes regulated by fibroblast growth factors (FGFs). Heparan sulfate (HS) regulates the activity of FGFs by acting as a coreceptor at the cell surface, enhancing FGF-FGFR affinity, and being a storage reservoir for FGFs in the extracellular matrix (ECM). Here we demonstrate a critical role for heparanase during mouse submandibular gland (SMG) branching morphogenesis. Heparanase, an endoglycosidase, colocalized with perlecan in the basement membrane and in epithelial clefts of SMGs. Inhibition of heparanase activity in organ culture decreased branching morphogenesis, and this inhibition was rescued specifically by FGF10 and not by other FGFs. By contrast, exogenous heparanase increased SMG branching and MAPK signaling and, surprisingly, when isolated epithelia were cultured in a three-dimensional ECM with FGF10, it increased the number of lateral branches and end buds. In a solid-phase binding assay,an FGF10-FGFR2b complex was released from the ECM by heparanase. In addition,surface plasmon resonance (SPR) analysis showed that FGF10 and the FGF10-FGFR2b complex bound to purified perlecan HS and could be released by heparanase. We used the FGF10-FGFR2b complex as a probe for HS in SMGs, and it colocalized with perlecan in the basement membrane and partly colocalized with syndecan 1 in the epithelium, and binding was reduced by treatment with heparanase. In summary, our results show heparanase releases FGF10 from perlecan HS in the basement membrane, increasing MAPK signaling, epithelial clefting, and lateral branch formation, which results in increased branching morphogenesis.<\/jats:p>","DOI":"10.1242\/dev.011171","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T23:10:23Z","timestamp":1193267423000},"page":"4177-4186","source":"Crossref","is-referenced-by-count":145,"title":["Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis"],"prefix":"10.1242","volume":"134","author":[{"given":"Vaishali N.","family":"Patel","sequence":"first","affiliation":[{"name":"Matrix and Morphogenesis Unit, Laboratory of Cell and Developmental Biology,National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, MD, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Knox","sequence":"additional","affiliation":[{"name":"Matrix and Morphogenesis Unit, Laboratory of Cell and Developmental Biology,National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, MD, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Likar","sequence":"additional","affiliation":[{"name":"Matrix and Morphogenesis Unit, Laboratory of Cell and Developmental Biology,National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, MD, USA."},{"name":"Howard Hughes Medical Institute-National Institutes of Health Research Scholars Program, Bethesda, MD, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin A.","family":"Lathrop","sequence":"additional","affiliation":[{"name":"Matrix and Morphogenesis Unit, Laboratory of Cell and Developmental Biology,National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, MD, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rydhwana","family":"Hossain","sequence":"additional","affiliation":[{"name":"Matrix and Morphogenesis Unit, Laboratory of Cell and Developmental Biology,National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, MD, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavash","family":"Eftekhari","sequence":"additional","affiliation":[{"name":"Matrix and Morphogenesis Unit, Laboratory of Cell and Developmental Biology,National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, MD, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Whitelock","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, University of New South Wales, Sydney,Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Elkin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem,Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Vlodavsky","sequence":"additional","affiliation":[{"name":"Cancer and Vascular Biology Research Center, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Matrix and Morphogenesis Unit, Laboratory of Cell and Developmental Biology,National Institute of Dental and Craniofacial Research, National Institutes of Health, 30 Convent Drive, Bethesda, MD, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","reference":[{"key":"2021042621045453700_REF1","doi-asserted-by":"crossref","unstructured":"Abboud-Jarrous, G., Rangini-Guetta, Z., Aingorn, H., Atzmon, R.,Elgavish, S., Peretz, T. and Vlodavsky, I. (2005). Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase. J. Biol. Chem.280,13568-13575.","DOI":"10.1074\/jbc.M413370200"},{"key":"2021042621045453700_REF2","doi-asserted-by":"crossref","unstructured":"Allen, B. L. and Rapraeger, A. C. (2003). Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J. Cell Biol.163,637-648.","DOI":"10.1083\/jcb.200307053"},{"key":"2021042621045453700_REF3","doi-asserted-by":"crossref","unstructured":"Allen, B. L., Filla, M. S. and Rapraeger, A. C.(2001). Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J. Cell Biol.155,845-858.","DOI":"10.1083\/jcb.200106075"},{"key":"2021042621045453700_REF4","doi-asserted-by":"crossref","unstructured":"Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J. R. and Yamada, Y. (1999). Perlecan is essential for cartilage and cephalic development. Nat. Genet.23,354-358.","DOI":"10.1038\/15537"},{"key":"2021042621045453700_REF5","doi-asserted-by":"crossref","unstructured":"Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G. and Yayon, A. (1994). Perlecan, basal lamina proteoglycan,promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell79,1005-1013.","DOI":"10.1016\/0092-8674(94)90031-0"},{"key":"2021042621045453700_REF6","doi-asserted-by":"crossref","unstructured":"Bame, K. J. (2001). Heparanases:endoglycosidases that degrade heparan sulfate proteoglycans. Glycobiology11,91R-98R.","DOI":"10.1093\/glycob\/11.6.91R"},{"key":"2021042621045453700_REF7","doi-asserted-by":"crossref","unstructured":"Bishop, J. R., Schuksz, M. and Esko, J. D.(2007). Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature446,1030-1037.","DOI":"10.1038\/nature05817"},{"key":"2021042621045453700_REF8","doi-asserted-by":"crossref","unstructured":"Cohen, E., Atzmon, R., Vlodavsky, I. and Ilan, N.(2005). Heparanase processing by lysosomal\/endosomal protein preparation. FEBS Lett.579,2334-2338.","DOI":"10.1016\/j.febslet.2005.03.030"},{"key":"2021042621045453700_REF9","doi-asserted-by":"crossref","unstructured":"Costell, M., Gustafsson, E., Aszodi, A., Morgelin, M., Bloch,W., Hunziker, E., Addicks, K., Timpl, R. and Fassler, R.(1999). Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol.147,1109-1122.","DOI":"10.1083\/jcb.147.5.1109"},{"key":"2021042621045453700_REF10","doi-asserted-by":"crossref","unstructured":"De Moerlooze, L., Spencer-Dene, B., Revest, J., Hajihosseini,M., Rosewell, I. and Dickson, C. (2000). An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development127,483-492.","DOI":"10.1242\/dev.127.3.483"},{"key":"2021042621045453700_REF11","doi-asserted-by":"crossref","unstructured":"Elkin, M., Ilan, N., Ishai-Michaeli, R., Friedmann, Y., Papo,O., Pecker, I. and Vlodavsky, I. (2001). Heparanase as mediator of angiogenesis: mode of action. FASEB J.15,1661-1663.","DOI":"10.1096\/fj.00-0895fje"},{"key":"2021042621045453700_REF12","doi-asserted-by":"crossref","unstructured":"Entesarian, M., Matsson, H., Klar, J., Bergendal, B., Olson, L.,Arakaki, R., Hayashi, Y., Ohuchi, H., Falahat, B., Bolstad, A. I. et al.(2005). Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands. Nat. Genet.37,125-127.","DOI":"10.1038\/ng1507"},{"key":"2021042621045453700_REF13","doi-asserted-by":"crossref","unstructured":"Entesarian, M., Dahlqvist, J., Shashi, V., Stanley, C. S.,Falahat, B., Reardon, W. and Dahl, N. (2007). FGF10 missense mutations in aplasia of lacrimal and salivary glands (ALSG). Eur. J. Hum. Genet. 15,379-382.","DOI":"10.1038\/sj.ejhg.5201762"},{"key":"2021042621045453700_REF14","doi-asserted-by":"crossref","unstructured":"Gingis-Velitski, S., Zetser, A., Kaplan, V., Ben-Zaken, O.,Cohen, E., Levy-Adam, F., Bashenko, Y., Flugelman, M. Y., Vlodavsky, I. and Ilan, N. (2004). Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans. J. Biol. Chem.279,44084-44092.","DOI":"10.1074\/jbc.M402131200"},{"key":"2021042621045453700_REF15","doi-asserted-by":"crossref","unstructured":"Hirata, A. and Nakamura, H. (2006). Localization of perlecan and heparanase in Hertwig's epithelial root sheath during root formation in mouse molars. J. Histochem. Cytochem.54,1105-1113.","DOI":"10.1369\/jhc.5A6883.2006"},{"key":"2021042621045453700_REF16","doi-asserted-by":"crossref","unstructured":"Hoffman, M. P., Kidder, B. L., Steinberg, Z. L., Lakhani, S.,Ho, S., Kleinman, H. K. and Larsen, M. (2002). Gene expression profiles of mouse submandibular gland development: FGFR1 regulates branching morphogenesis in vitro through BMP- and FGF-dependent mechanisms. Development129,5767-5778.","DOI":"10.1242\/dev.00172"},{"key":"2021042621045453700_REF17","doi-asserted-by":"crossref","unstructured":"Ibrahimi, O. A., Zhang, F., Hrstka, S. C., Mohammadi, M. and Linhardt, R. J. (2004). Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry43,4724-4730.","DOI":"10.1021\/bi0352320"},{"key":"2021042621045453700_REF18","doi-asserted-by":"crossref","unstructured":"Iozzo, R. V. (2001). Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J. Clin. Invest.108,165-167.","DOI":"10.1172\/JCI200113560"},{"key":"2021042621045453700_REF19","doi-asserted-by":"crossref","unstructured":"Iozzo, R. V. (2005). Basement membrane proteoglycans: from cellar to ceiling. Nat. Rev. Mol. Cell Biol.6,646-656.","DOI":"10.1038\/nrm1702"},{"key":"2021042621045453700_REF20","doi-asserted-by":"crossref","unstructured":"Ishai-Michaeli, R., Eldor, A. and Vlodavsky, I.(1990). Heparanase activity expressed by platelets, neutrophils,and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul.1,833-842.","DOI":"10.1091\/mbc.1.11.833"},{"key":"2021042621045453700_REF21","doi-asserted-by":"crossref","unstructured":"Izvolsky, K. I., Shoykhet, D., Yang, Y., Yu, Q., Nugent, M. A. and Cardoso, W. V. (2003a). Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev. Biol.258,185-200.","DOI":"10.1016\/S0012-1606(03)00114-3"},{"key":"2021042621045453700_REF22","doi-asserted-by":"crossref","unstructured":"Izvolsky, K. I., Zhong, L., Wei, L., Yu, Q., Nugent, M. A. and Cardoso, W. V. (2003b). Heparan sulfates expressed in the distal lung are required for Fgf10 binding to the epithelium and for airway branching. Am. J. Physiol.285,L838-L846.","DOI":"10.1152\/ajplung.00081.2003"},{"key":"2021042621045453700_REF23","doi-asserted-by":"crossref","unstructured":"Jakobsson, L., Kreuger, J., Holmborn, K., Lundin, L., Eriksson,I., Kjellen, L. and Claesson-Welsh, L. (2006). Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev. Cell10,625-634.","DOI":"10.1016\/j.devcel.2006.03.009"},{"key":"2021042621045453700_REF24","doi-asserted-by":"crossref","unstructured":"Jaskoll, T., Abichaker, G., Witcher, D., Sala, F. G., Bellusci,S., Hajihosseini, M. K. and Melnick, M. (2005). FGF10\/FGFR2b signaling plays essential roles during in vivo embryonic submandibular salivary gland morphogenesis. BMC Dev. Biol.5, 11.","DOI":"10.1186\/1471-213X-5-11"},{"key":"2021042621045453700_REF25","doi-asserted-by":"crossref","unstructured":"Kan, M., Wu, X., Wang, F. and McKeehan, W. L.(1999). Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J. Biol. Chem.274,15947-15952.","DOI":"10.1074\/jbc.274.22.15947"},{"key":"2021042621045453700_REF26","doi-asserted-by":"crossref","unstructured":"Kato, M., Wang, H., Kainulainen, V., Fitzgerald, M. L.,Ledbetter, S., Ornitz, D. M. and Bernfield, M. (1998). Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat. Med.4, 691-697.","DOI":"10.1038\/nm0698-691"},{"key":"2021042621045453700_REF27","doi-asserted-by":"crossref","unstructured":"Knox, S. M. and Whitelock, J. M. (2006). Perlecan: how does one molecule do so many things? Cell. Mol. Life Sci.63,2435-2445.","DOI":"10.1007\/s00018-006-6162-z"},{"key":"2021042621045453700_REF28","doi-asserted-by":"crossref","unstructured":"Knox, S., Merry, C., Stringer, S., Melrose, J. and Whitelock,J. (2002). Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors. J. Biol. Chem.277,14657-14665.","DOI":"10.1074\/jbc.M111826200"},{"key":"2021042621045453700_REF29","doi-asserted-by":"crossref","unstructured":"Levy-Adam, F., Abboud-Jarrous, G., Guerrini, M., Beccati, D.,Vlodavsky, I. and Ilan, N. (2005). Identification and characterization of heparin\/heparan sulfate binding domains of the endoglycosidase heparanase. J. Biol. Chem.280,20457-20466.","DOI":"10.1074\/jbc.M414546200"},{"key":"2021042621045453700_REF30","doi-asserted-by":"crossref","unstructured":"Melrose, J., Roughley, P., Knox, S., Smith, S., Lord, M. and Whitelock, J. (2006). The structure, location, and function of perlecan, a prominent pericellular proteoglycan of fetal, postnatal, and mature hyaline cartilages. J. Biol. Chem.281,36905-36914.","DOI":"10.1074\/jbc.M608462200"},{"key":"2021042621045453700_REF31","doi-asserted-by":"crossref","unstructured":"Miao, H. Q., Elkin, M., Aingorn, E., Ishai-Michaeli, R., Stein,C. A. and Vlodavsky, I. (1999). Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int. J. Cancer83,424-431.","DOI":"10.1002\/(SICI)1097-0215(19991029)83:3<424::AID-IJC20>3.0.CO;2-L"},{"key":"2021042621045453700_REF32","doi-asserted-by":"crossref","unstructured":"Milunsky, J. M., Zhao, G., Maher, T. A., Colby, R. and Everman,D. B. (2006). LADD syndrome is caused by FGF10 mutations. Clin. Genet.69,349-354.","DOI":"10.1111\/j.1399-0004.2006.00597.x"},{"key":"2021042621045453700_REF33","doi-asserted-by":"crossref","unstructured":"Mohammadi, M., Olsen, S. K. and Goetz, R.(2005a). A protein canyon in the FGF-FGF receptor dimer selects from an a la carte menu of heparan sulfate motifs. Curr. Opin. Struct. Biol.15,506-516.","DOI":"10.1016\/j.sbi.2005.09.002"},{"key":"2021042621045453700_REF34","doi-asserted-by":"crossref","unstructured":"Mohammadi, M., Olsen, S. K. and Ibrahimi, O. A.(2005b). Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev.16,107-137.","DOI":"10.1016\/j.cytogfr.2005.01.008"},{"key":"2021042621045453700_REF35","doi-asserted-by":"crossref","unstructured":"Mongiat, M., Taylor, K., Otto, J., Aho, S., Uitto, J.,Whitelock, J. M. and Iozzo, R. V. (2000). The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J. Biol. Chem.275,7095-7100.","DOI":"10.1074\/jbc.275.10.7095"},{"key":"2021042621045453700_","doi-asserted-by":"crossref","unstructured":"Mori, Y., Yoshida, K., Morita, T. and Nakanishi, Y.(1994). Branching morphogenesis of mouse embryonic submandibular epithelia cultured under three different conditions. Dev. Growth Differ.36,529-539.","DOI":"10.1111\/j.1440-169X.1994.00529.x"},{"key":"2021042621045453700_REF37","doi-asserted-by":"crossref","unstructured":"Nadav, L., Eldor, A., Yacoby-Zeevi, O., Zamir, E., Pecker, I.,Ilan, N., Geiger, B., Vlodavsky, I. and Katz, B. Z. (2002). Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J. Cell Sci.115,2179-2187.","DOI":"10.1242\/jcs.115.10.2179"},{"key":"2021042621045453700_REF38","doi-asserted-by":"crossref","unstructured":"Nakanishi, Y., Uematsu, J., Takamatsu, H., Fukuda, T. and Yoshida, K. (1993). Removal of heparan sulfate chains halted epithelial branching morphogenesis of the developing mouse submandibular gland in vitro. Dev. Growth Differ.35,371-384.","DOI":"10.1111\/j.1440-169X.1993.00371.x"},{"key":"2021042621045453700_REF39","unstructured":"Ohuchi, H. (2000). Roles for FGF-FGFR signaling during vertebrate development. Hum. Cell13,169-175."},{"key":"2021042621045453700_REF40","doi-asserted-by":"crossref","unstructured":"Pantoliano, M. W., Horlick, R. A., Springer, B. A., Van Dyk, D. E., Tobery, T., Wetmore, D. R., Lear, J. D., Nahapetian, A. T., Bradley, J. D. and Sisk, W. P. (1994). Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry33,10229-10248.","DOI":"10.1021\/bi00200a003"},{"key":"2021042621045453700_REF41","doi-asserted-by":"crossref","unstructured":"Patel, V. N., Rebustini, I. T. and Hoffman, M. P.(2006). Salivary gland branching morphogenesis. Differentiation74,349-364.","DOI":"10.1111\/j.1432-0436.2006.00088.x"},{"key":"2021042621045453700_REF42","doi-asserted-by":"crossref","unstructured":"Rebustini, I. T., Patel, V. N., Stewart, J. S., Layvey, A.,Georges-Labouesse, E., Miner, J. H. and Hoffman, M. P.(2007). Laminin \u03b15 is necessary for submandibular gland epithelial morphogenesis and influences FGFR expression through \u03b21 integrin signaling. Dev. Biol.308, 15-29.","DOI":"10.1016\/j.ydbio.2007.04.031"},{"key":"2021042621045453700_REF43","doi-asserted-by":"crossref","unstructured":"Reiland, J., Sanderson, R. D., Waguespack, M., Barker, S. A.,Long, R., Carson, D. D. and Marchetti, D. (2004). Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J. Biol. Chem.279,8047-8055.","DOI":"10.1074\/jbc.M304872200"},{"key":"2021042621045453700_REF44","doi-asserted-by":"crossref","unstructured":"Reiland, J., Kempf, D., Roy, M., Denkins, Y. and Marchetti,D. (2006). FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells. Neoplasia8,596-606.","DOI":"10.1593\/neo.06244"},{"key":"2021042621045453700_REF45","doi-asserted-by":"crossref","unstructured":"Sanderson, R. D., Yang, Y., Suva, L. J. and Kelly, T.(2004). Heparan sulfate proteoglycans and heparanase - partners in osteolytic tumor growth and metastasis. Matrix Biol.23,341-352.","DOI":"10.1016\/j.matbio.2004.08.004"},{"key":"2021042621045453700_REF46","doi-asserted-by":"crossref","unstructured":"Sanderson, R. D., Yang, Y., Kelly, T., MacLeod, V., Dai, Y. and Theus, A. (2005). Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies. J. Cell. Biochem.96,897-905.","DOI":"10.1002\/jcb.20602"},{"key":"2021042621045453700_REF47","doi-asserted-by":"crossref","unstructured":"Schubert, S. Y., Ilan, N., Shushy, M., Ben-Izhak, O., Vlodavsky,I. and Goldshmidt, O. (2004). Human heparanase nuclear localization and enzymatic activity. Lab. Invest.84,535-544.","DOI":"10.1038\/labinvest.3700084"},{"key":"2021042621045453700_REF48","doi-asserted-by":"crossref","unstructured":"Sekine, K., Ohuchi, H., Fujiwara, M., Yamasaki, M., Yoshizawa,T., Sato, T., Yagishita, N., Matsui, D., Koga, Y., Itoh, N. et al.(1999). Fgf10 is essential for limb and lung formation. Nat. Genet.21,138-141.","DOI":"10.1038\/5096"},{"key":"2021042621045453700_REF49","doi-asserted-by":"crossref","unstructured":"Steinberg, Z., Myers, C., Heim, V. M., Lathrop, C. A.,Rebustini, I. T., Stewart, J. S., Larsen, M. and Hoffman, M. P.(2005). FGFR2b signaling regulates ex vivo submandibular gland epithelial cell proliferation and branching morphogenesis. Development132,1223-1234.","DOI":"10.1242\/dev.01690"},{"key":"2021042621045453700_REF50","doi-asserted-by":"crossref","unstructured":"Thompson, H. A. and Spooner, B. S. (1982). Inhibition of branching morphogenesis and alteration of glycosaminoglycan biosynthesis in salivary glands treated with beta-D-xyloside. Dev. Biol.89,417-424.","DOI":"10.1016\/0012-1606(82)90330-X"},{"key":"2021042621045453700_REF51","doi-asserted-by":"crossref","unstructured":"Thompson, H. A. and Spooner, B. S. (1983). Proteoglycan and glycosaminoglycan synthesis in embryonic mouse salivary glands: effects of beta-D-xyloside, an inhibitor of branching morphogenesis. J. Cell Biol.96,1443-1450.","DOI":"10.1083\/jcb.96.5.1443"},{"key":"2021042621045453700_REF52","doi-asserted-by":"crossref","unstructured":"Umeda, Y., Miyazaki, Y., Shiinoki, H., Higashiyama, S.,Nakanishi, Y. and Hieda, Y. (2001). Involvement of heparin-binding EGF-like growth factor and its processing by metalloproteinases in early epithelial morphogenesis of the submandibular gland. Dev. Biol.237,202-211.","DOI":"10.1006\/dbio.2001.0351"},{"key":"2021042621045453700_REF53","doi-asserted-by":"crossref","unstructured":"Vlodavsky, I. and Friedmann, Y. (2001). Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J. Clin. Invest.108,341-347.","DOI":"10.1172\/JCI13662"},{"key":"2021042621045453700_REF54","doi-asserted-by":"crossref","unstructured":"Vlodavsky, I., Miao, H. Q., Medalion, B., Danagher, P. and Ron,D. (1996). Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev.15,177-186.","DOI":"10.1007\/BF00437470"},{"key":"2021042621045453700_REF55","doi-asserted-by":"crossref","unstructured":"Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon,R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I. et al. (1999). Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat. Med.5,793-802.","DOI":"10.1038\/10518"},{"key":"2021042621045453700_REF56","doi-asserted-by":"crossref","unstructured":"Vlodavsky, I., Goldshmidt, O., Zcharia, E., Metzger, S.,Chajek-Shaul, T., Atzmon, R., Guatta-Rangini, Z. and Friedmann, Y.(2001). Molecular properties and involvement of heparanase in cancer progression and normal development. Biochimie83,831-839.","DOI":"10.1016\/S0300-9084(01)01318-9"},{"key":"2021042621045453700_REF57","doi-asserted-by":"crossref","unstructured":"Vlodavsky, I., Goldshmidt, O., Zcharia, E., Atzmon, R.,Rangini-Guatta, Z., Elkin, M., Peretz, T. and Friedmann, Y.(2002). Mammalian heparanase: involvement in cancer metastasis,angiogenesis and normal development. Semin. Cancer Biol.12,121-129.","DOI":"10.1006\/scbi.2001.0420"},{"key":"2021042621045453700_REF58","doi-asserted-by":"crossref","unstructured":"Vreys, V., Delande, N., Zhang, Z., Coomans, C., Roebroek, A.,Durr, J. and David, G. (2005). Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans. J. Biol. Chem.280,33141-33148.","DOI":"10.1074\/jbc.M503007200"},{"key":"2021042621045453700_REF59","doi-asserted-by":"crossref","unstructured":"Whitelock, J. M. and Iozzo, R. V. (2005). Heparan sulfate: a complex polymer charged with biological activity. Chem. Rev.105,2745-2764.","DOI":"10.1021\/cr010213m"},{"key":"2021042621045453700_REF60","doi-asserted-by":"crossref","unstructured":"Whitelock, J. M., Murdoch, A. D., Iozzo, R. V. and Underwood, P. A. (1996). The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin,collagenase, plasmin, and heparanases. J. Biol. Chem.271,10079-10086.","DOI":"10.1074\/jbc.271.17.10079"},{"key":"2021042621045453700_REF61","doi-asserted-by":"crossref","unstructured":"Yang, Y., Macleod, V., Miao, H. Q., Theus, A., Zhan, F.,Shaughnessy, J. D., Jr, Sawyer, J., Li, J. P., Zcharia, E., Vlodavsky, I. et al. (2007). Heparanase enhances Syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J. Biol. Chem.282,13326-13333.","DOI":"10.1074\/jbc.M611259200"},{"key":"2021042621045453700_REF62","doi-asserted-by":"crossref","unstructured":"Zcharia, E., Metzger, S., Chajek-Shaul, T., Friedmann, Y.,Pappo, O., Aviv, A., Elkin, M., Pecker, I., Peretz, T. and Vlodavsky, I.(2001). Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis. J. Mammary Gland Biol. Neoplasia6,311-322.","DOI":"10.1023\/A:1011375624902"},{"key":"2021042621045453700_REF63","doi-asserted-by":"crossref","unstructured":"Zcharia, E., Philp, D., Edovitsky, E., Aingorn, H., Metzger, S.,Kleinman, H. K., Vlodavsky, I. and Elkin, M. (2005a). Heparanase regulates murine hair growth. Am. J. Pathol.166,999-1008.","DOI":"10.1016\/S0002-9440(10)62321-8"},{"key":"2021042621045453700_REF64","doi-asserted-by":"crossref","unstructured":"Zcharia, E., Zilka, R., Yaar, A., Yacoby-Zeevi, O., Zetser, A.,Metzger, S., Sarid, R., Naggi, A., Casu, B., Ilan, N. et al.(2005b). Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J.19,211-221.","DOI":"10.1096\/fj.04-1970com"},{"key":"2021042621045453700_REF65","doi-asserted-by":"crossref","unstructured":"Zetser, A., Levy-Adam, F., Kaplan, V., Gingis-Velitski, S.,Bashenko, Y., Schubert, S., Flugelman, M. Y., Vlodavsky, I. and Ilan, N.(2004). Processing and activation of latent heparanase occurs in lysosomes. J. Cell Sci.117,2249-2258.","DOI":"10.1242\/jcs.01068"}],"container-title":["Development"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/dev\/article-pdf\/134\/23\/4177\/1528414\/4177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dev\/article-pdf\/134\/23\/4177\/1528414\/4177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T13:59:53Z","timestamp":1684072793000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dev\/article\/134\/23\/4177\/64566\/Heparanase-cleavage-of-perlecan-heparan-sulfate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":65,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2007,12,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dev.011171","relation":{},"ISSN":["1477-9129","0950-1991"],"issn-type":[{"value":"1477-9129","type":"electronic"},{"value":"0950-1991","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12,1]]}}}